A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer
一项针对晚期实体瘤以及与瑞戈非尼联合治疗转移性结直肠癌的诺法嗪利单抗(一种抗PD-1抗体)的首次人体I期研究
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-023-02431-7
Day, Daphne; Park, John J; Coward, Jermaine; Markman, Ben; Lemech, Charlotte; Kuo, James C; Prawira, Amy; Brown, Michael P; Bishnoi, Sarwan; Kotasek, Dusan; Strother, R Matthew; Cosman, Rasha; Su, Rila; Ma, Yiding; Yue, Zenglian; Hu, Hui-Han; Wu, Rachel; Li, Peiqi; Tse, Archie N